Orion
Veli-Matti Mattila currently serves as Chair at Orion Corporation, a position held since March 2024. Prior to this role, Veli-Matti Mattila was the CEO of Elisa from May 2003 until February 2024, showcasing extensive leadership experience in the telecommunications sector.
This person is not in any teams
This person is not in any offices
Orion
1 followers
Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are neurological disorders, oncology, Finnish heritage rare diseases and respiratory diseases for which Orion develops inhaled Easyhaler® pulmonary drugs.